av/transgene--big.svg

FR:TRANSGENE

Transgene

  • Stock

0.61

−0.98%

−0.01

EUR last updated 24/07 01:52:16

Last Close

0.61

02/05 08:26

Market Cap

106.75M

Beta: -

Volume Today

16.42K

Avg: -

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Transgene SA, a biotechnology company, focuses on designing and developing therapeutic vaccines and oncolytic viruses for the treatment of cancer and infectious diseases. It is involved in developing TG4050, a therapeutic vaccine that is in phase I clinical trial for the treatment of ovarian cancer, and human papilloma virus (HPV)-negative head and neck cancers; TG4001, a thera...Show More